XML 409 R129.htm IDEA: XBRL DOCUMENT v3.23.1
Non-Controlling Interest - Disclosure of changes in equity classified non-controlling ownership interests in subsidiaries (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Non-Controlling Interests [Line Items]      
Equity at beginning of period $ 584,147 $ 653,539 $ 650,398
Share of comprehensive income (loss) (37,444) (62,709) 5,037
NCI exercise of share options in subsidiaries 7 66  
Equity settled share-based awards 13,567 13,361 10,627
Acquisition of subsidiary non-controlling interest   (968)  
Equity at end of period 547,589 584,147 653,539
Non-controlling interests      
Non-Controlling Interests [Line Items]      
Equity at beginning of period (9,368) (16,209) (17,639)
Share of comprehensive income (loss) 13,290 (2,151) (1,417)
Deconsolidation of subsidiary 11,904    
NCI exercise of share-based awards in subsidiaries - change in NCI interest   (5,922)  
NCI exercise of share options in subsidiaries (15,164) (5,922)  
Equity settled share-based awards 4,711 6,252 2,822
Acquisition of subsidiary non-controlling interest   8,668  
Other (4) (6) 24
Equity at end of period 5,369 (9,368) (16,209)
Internal      
Non-Controlling Interests [Line Items]      
Share of comprehensive income (loss) (121,118) (64,753) (41,964)
Internal | Non-controlling interests      
Non-Controlling Interests [Line Items]      
Equity at beginning of period 0 (8,567) (8,682)
Share of comprehensive income (loss) 0 (96) (191)
Deconsolidation of subsidiary 0    
NCI exercise of share-based awards in subsidiaries - change in NCI interest   0  
NCI exercise of share options in subsidiaries 0    
Equity settled share-based awards 0 (4) 305
Acquisition of subsidiary non-controlling interest   8,668  
Other 0 0 0
Equity at end of period 0 0 (8,567)
Controlled founded entities      
Non-Controlling Interests [Line Items]      
Share of comprehensive income (loss) 99,075 (42,917) (45,411)
Controlled founded entities | Non-controlling interests      
Non-Controlling Interests [Line Items]      
Equity at beginning of period 1,634 2,966 1,465
Share of comprehensive income (loss) 13,604 (1,634) (905)
Deconsolidation of subsidiary 0    
NCI exercise of share-based awards in subsidiaries - change in NCI interest   (5,922)  
NCI exercise of share options in subsidiaries (15,164)    
Equity settled share-based awards 4,703 6,224 2,395
Acquisition of subsidiary non-controlling interest   0  
Other 0 0 11
Equity at end of period 4,778 1,634 2,966
Non-controlled founded entities      
Non-Controlling Interests [Line Items]      
Share of comprehensive income (loss) (5,085) (7,010) (6,826)
Non-controlled founded entities | Non-controlling interests      
Non-Controlling Interests [Line Items]      
Equity at beginning of period (11,585) (11,181) (11,016)
Share of comprehensive income (loss) (330) (436) (306)
Deconsolidation of subsidiary 11,904    
NCI exercise of share-based awards in subsidiaries - change in NCI interest   0  
NCI exercise of share options in subsidiaries 0    
Equity settled share-based awards 8 32 122
Acquisition of subsidiary non-controlling interest   0  
Other 2 0 19
Equity at end of period 0 (11,585) (11,181)
Parent company and other      
Non-Controlling Interests [Line Items]      
Share of comprehensive income (loss) (10,316) 51,971 99,238
Parent company and other | Non-controlling interests      
Non-Controlling Interests [Line Items]      
Equity at beginning of period 583 574 593
Share of comprehensive income (loss) 15 15 (15)
Deconsolidation of subsidiary 0    
NCI exercise of share-based awards in subsidiaries - change in NCI interest   0  
NCI exercise of share options in subsidiaries 0    
Equity settled share-based awards 0 0 0
Acquisition of subsidiary non-controlling interest   0  
Other (6) (6) (6)
Equity at end of period $ 592 $ 583 $ 574